MICHAEL NARACHI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL NARACHI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL NARACHI. MICHAEL NARACHI is Director in AMAG PHARMACEUTICALS INC. ($AVM) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and CEO & President in Orexigen Therapeutics, Inc. ($OREX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).
Latest Insider Trading Transactions of MICHAEL NARACHI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, EIGR, OREX, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 93.20 | 4,125 | 384,450 | 4,125 | |
| Jun 28 2021 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 2,145 | 0 | 14,445 | 12.3 K to 14.4 K (+17.44 %) |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 2,550 | 0 | 12,300 | 9.8 K to 12.3 K (+26.15 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Oct 17 2017 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 0.00 | 252,000 | 0 | 252,000 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 02 2017 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 1.55 | 626 | 970 | 8,356 | 7.7 K to 8.4 K (+8.10 %) |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 15.00 | 157,500 | 2,362,500 | 157,500 | |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 4.10 | 315,000 | 1,291,500 | 315,000 | |
| Dec 02 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 1.67 | 802 | 1,339 | 6,312 | 5.5 K to 6.3 K (+14.56 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 15.00 | 63,000 | 945,000 | 63,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 15.00 | 315,000 | 4,725,000 | 315,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 4.02 | 105,000 | 422,100 | 105,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 4.02 | 525,000 | 2,110,500 | 525,000 | |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Jun 02 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 0.34 | 8,777 | 2,984 | 69,285 | 60.5 K to 69.3 K (+14.51 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 0.00 | 800,000 | 0 | 800,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 1.78 | 700,000 | 1,246,000 | 700,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 2.03 | 1,761 | 3,575 | 60,508 | 58.7 K to 60.5 K (+3.00 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 4.17 | 721 | 3,007 | 58,747 | 58 K to 58.7 K (+1.24 %) |
| Jun 22 2015 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Option Exercise | A | 97.85 | 7,500 | 733,875 | 7,500 | ||
| Jun 05 2015 | EIGR | Eiger BioPharmaceu ... | NARACHI MICHAEL | Director | Option Exercise | A | 2.16 | 10,000 | 21,600 | 50,000 | |
| Feb 24 2015 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 55.57 | 17,500 | 972,475 | 17,500 | |
| Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 41.16 | 8,801 | 362,249 | 8,801 |
Page: 1